Clinical Trial Update: The Analgesic Effect of Combined Treatment With Intranasal S-ketamine and Intranasal Midazolam [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the analgesic effect of combining intranasal S-ketamine and intranasal midazolam in spinal stenosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Stenosis

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)
• Versed (Midazolam)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Analgesia, Patient-controlled, Spinal Stenosis | Phase 2, Phase 3 | Status: COMPLETED